FeesSafety
Pluang+

Anthropic warns it may soon create AI capable of recursive self-improvement, raising safety and control concerns.

Market News
03 Nov 2026, 00:14 WIB
TechCrunch
View Source
Neutral
Anthropic warns it may soon create AI capable of recursive self-improvement, raising safety and control concerns.

Anthropic's updated S-1 filing reveals it is close to developing an AI model capable of recursive self-improvement (RSI), where AI can autonomously enhance its own capabilities. This milestone could lead to rapid AI advancements but also poses significant safety risks if progress outpaces human oversight. The company emphasizes its commitment to maintaining human control and updating safety policies as it approaches this threshold. This development highlights both the promise and peril of advanced AI technology, prompting calls for careful governance.

Anthropic's progress toward recursive self-improving AI is notable as Pluang's Technology sector saw 111 of 150 US stocks fall today. For readers following technology stocks, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: Godaddy Inc (GDDY) rose 9.88% to USD 116.35 with a typical hold time of 65 days and 70% sell order activity, while BlackBerry Limited (BB) dropped 8.92% to USD 8.37 with 93% buy order activity, and Intel Corp (INTC) declined 8.61% to USD 60.10 with 58% buy order activity and a typical hold time of 116 days.

More News

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
33 minutes ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
33 minutes ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
2 hours ago
Olin Corp remains a Buy with 20%+ upside, backed by price hikes and strong cash flow despite market challenges.

Olin Corp remains a Buy with 20%+ upside, backed by price hikes and strong cash flow despite market challenges.

Olin Corporation is rated a Buy with over 20% upside potential due to self-help measures and attractive free cash flow yield. Despite facing weak markets and pressures from Chinese exports, Olin's Q3 results showed margin protection through price inc...

Market News
Bullish
5 hours ago
Whitecap Resources posts strong Q3, raises dividend and production outlook after merger benefits

Whitecap Resources posts strong Q3, raises dividend and production outlook after merger benefits

Whitecap Resources reported strong third-quarter results driven by higher oil prices and synergies from a recent merger of two undervalued companies. The company raised its monthly dividend to C$0.0617 per share, reflecting solid free cash flow and d...

Company Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App